These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 30300165)
21. Influence of mirtazapine on salivary cortisol in depressed patients. Laakmann G; Hennig J; Baghai T; Schüle C Neuropsychobiology; 2003; 47(1):31-6. PubMed ID: 12606843 [TBL] [Abstract][Full Text] [Related]
22. CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study. Olbrich S; Tränkner A; Surova G; Gevirtz R; Gordon E; Hegerl U; Arns M J Psychiatr Res; 2016 Feb; 73():108-15. PubMed ID: 26714202 [TBL] [Abstract][Full Text] [Related]
23. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression. Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277 [TBL] [Abstract][Full Text] [Related]
24. Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder. Simon JS; Nemeroff CB J Clin Psychiatry; 2005 Oct; 66(10):1216-20. PubMed ID: 16259533 [TBL] [Abstract][Full Text] [Related]
25. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy. Grosse L; Carvalho LA; Birkenhager TK; Hoogendijk WJ; Kushner SA; Drexhage HA; Bergink V Psychopharmacology (Berl); 2016 May; 233(9):1679-88. PubMed ID: 25953327 [TBL] [Abstract][Full Text] [Related]
27. A viewpoint on aldosterone and BMI related brain morphology in relation to treatment outcome in patients with major depression. Murck H; Lehr L; Jezova D J Neuroendocrinol; 2023 Feb; 35(2):e13219. PubMed ID: 36539978 [TBL] [Abstract][Full Text] [Related]
28. Clinical features and drug induced side effects in early versus late antidepressant responders. Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418 [TBL] [Abstract][Full Text] [Related]
31. Psychophysiological and cortisol responses to psychological stress in depressed and nondepressed older men and women with elevated cardiovascular disease risk. Taylor CB; Conrad A; Wilhelm FH; Neri E; DeLorenzo A; Kramer MA; Giese-Davis J; Roth WT; Oka R; Cooke JP; Kraemer H; Spiegel D Psychosom Med; 2006; 68(4):538-46. PubMed ID: 16868262 [TBL] [Abstract][Full Text] [Related]
32. Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder. Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Modell S; Künzel H; Müller-Oerlinghausen B; Bauer M J Psychiatr Res; 2003; 37(2):135-43. PubMed ID: 12842167 [TBL] [Abstract][Full Text] [Related]
33. 5-HTT mRNA level as a potential biomarker of treatment response in patients with major depression in a clinical trial. Kao WT; Chang CL; Lung FW J Affect Disord; 2018 Oct; 238():597-608. PubMed ID: 29957477 [TBL] [Abstract][Full Text] [Related]
34. Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder. Sato Y; Yasui-Furukori N; Nakagami T; Saito M; Kaneko S Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):416-8. PubMed ID: 19166896 [TBL] [Abstract][Full Text] [Related]
35. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. DeRijk RH; Wüst S; Meijer OC; Zennaro MC; Federenko IS; Hellhammer DH; Giacchetti G; Vreugdenhil E; Zitman FG; de Kloet ER J Clin Endocrinol Metab; 2006 Dec; 91(12):5083-9. PubMed ID: 17018659 [TBL] [Abstract][Full Text] [Related]
36. Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression. Ormstad H; Dahl J; Verkerk R; Andreassen OA; Maes M Eur Neuropsychopharmacol; 2016 Aug; 26(8):1286-96. PubMed ID: 27237997 [TBL] [Abstract][Full Text] [Related]
37. Association between anxiety disorders and heart rate variability in The Netherlands Study of Depression and Anxiety (NESDA). Licht CM; de Geus EJ; van Dyck R; Penninx BW Psychosom Med; 2009 Jun; 71(5):508-18. PubMed ID: 19414616 [TBL] [Abstract][Full Text] [Related]
38. Early switching strategies in antidepressant non-responders: current evidence and future research directions. Kudlow PA; McIntyre RS; Lam RW CNS Drugs; 2014 Jul; 28(7):601-9. PubMed ID: 24831418 [TBL] [Abstract][Full Text] [Related]
39. Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression. Block T; Petrides G; Kushner H; Kalin N; Belanoff J; Schatzberg A J Clin Psychopharmacol; 2017 Oct; 37(5):505-511. PubMed ID: 28708736 [TBL] [Abstract][Full Text] [Related]